Regulatory T cell lineage specification by the forkhead transcription factor FoxP3

被引:1950
|
作者
Fontenot, JD [1 ]
Rasmussen, JP
Williams, LM
Dooley, JL
Farr, AG
Rudensky, AY
机构
[1] Univ Washington, Dept Immunol, Seattle, WA 98195 USA
[2] Univ Washington, Howard Hughes Med Inst, Seattle, WA 98195 USA
[3] Univ Washington, Dept Biol Struct, Seattle, WA 98195 USA
基金
美国国家卫生研究院;
关键词
D O I
10.1016/j.immuni.2005.01.016
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Regulatory T cell-mediated dominant tolerance has been demonstrated to play an important role in the prevention of autoimmunity. Here, we present data arguing that the forkhead transcription factor Foxp3 acts as the regulatory T cell lineage specification factor and mediator of the genetic mechanism of dominant tolerance. We show that expression of Foxp3 is highly restricted to the subset up of T cells and, irrespective of CD25 expression, correlates with suppressor activity. Induction of Foxp3 expression in nonregulatory T cells does not occur during pathogen-driven immune responses, and Foxp3 deficiency does not impact the functional responses of nonregulatory T cells. Furthermore, T cell-specific ablation of Foxp3 is sufficient to induce the identical early onset lymphoproliferative syndrome observed in Foxp3-deficient mice. Analysis of Foxp3 expression during thymic development suggests that this mechanism is not hard-wired but is dependent on TCR/MHC ligand interactions.
引用
收藏
页码:329 / 341
页数:13
相关论文
共 50 条
  • [31] Control of regulatory T-cell differentiation and function by T-cell receptor signalling and Foxp3 transcription factor complexes
    Ono, Masahiro
    IMMUNOLOGY, 2020, 160 (01) : 24 - 37
  • [32] The expression of the Forkhead Box Transcription Factor FoxP3 is associated with poor prognosis in melanoma
    Knol, A. C.
    Nguyen, J. M.
    Khammari, A.
    Quereux, G.
    Brocard, A.
    Dreno, B.
    JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2010, 130 (10) : 2521 - 2521
  • [33] Vaccination against the forkhead family transcription factor Foxp3 enhances tumor immunity
    Nair, Smita
    Boczkowski, David
    Fassnacht, Martin
    Pisetsky, David
    Gilboa, Eli
    CANCER RESEARCH, 2007, 67 (01) : 371 - 380
  • [34] Epigenetic control of FOXP3 expression: the key to a stable regulatory T-cell lineage?
    Jochen Huehn
    Julia K. Polansky
    Alf Hamann
    Nature Reviews Immunology, 2009, 9 : 83 - 89
  • [35] Foxp3, Regulatory T Cell, and Autoimmune Diseases
    Jin-Hui Tao
    Miao Cheng
    Jiang-Ping Tang
    Qin Liu
    Fan Pan
    Xiang-Pei Li
    Inflammation, 2017, 40 : 328 - 339
  • [36] Foxp3, Regulatory T Cell, and Autoimmune Diseases
    Tao, Jin-Hui
    Cheng, Miao
    Tang, Jiang-Ping
    Liu, Qin
    Pan, Fan
    Li, Xiang-Pei
    INFLAMMATION, 2017, 40 (01) : 328 - 339
  • [37] Nuclear Factor-κB Modulates Regulatory T Cell Development by Directly Regulating Expression of Foxp3 Transcription Factor
    Long, Meixiao
    Park, Sung-Gyoo
    Strickland, Ian
    Hayden, Mafthew S.
    Ghosh, Sankar
    IMMUNITY, 2009, 31 (06) : 921 - 931
  • [38] Blockage of FOXP3 transcription factor dimerization and FOXP3/AML1 interaction inhibits T regulatory cell activity: sequence optimization of a peptide inhibitor
    Lozano, Teresa
    Gorraiz, Marta
    Lasarte-Cia, Aritz
    Ruiz, Marta
    Rabal, Obdulia
    Oyarzabal, Julen
    Hervas-Stubbs, Sandra
    Llopiz, Diana
    Sarobe, Pablo
    Prieto, Jesus
    Casares, Noelia
    Lasarte, Juan Jose
    ONCOTARGET, 2017, 8 (42) : 71709 - 71724
  • [39] Domain requirements of the FoxP3 transcription factor for the development and function of regulatory T-cells
    Nishikawa, T.
    Takayama, A.
    Watarai, H.
    Taniguchi, M.
    Hori, S.
    IMMUNOLOGY, 2008, 125 : 121 - 121
  • [40] Assay development to validate RNAi candidates targeting FoxP3 transcription factor in adaptive regulatory T cell.
    Bajgelman, Marcio C.
    Brenneman, Randall J.
    Seales, Dawn
    Berezhnoy, Alexey
    Carvalho, Ana Carolina P.
    Gilboa, Eli
    MOLECULAR CANCER THERAPEUTICS, 2013, 12 (11)